AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. THAR
  4. [EFFECT] Tharimmune, Inc. SEC Filing

[EFFECT] Tharimmune, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 9, 2025 5:00 P.M.
Form: S-3
CIK: 0001861657
Company Name: Tharimmune, Inc.
File Number: 333-288518

Source:

Stock THAR logo
Tharimmune Inc

NASDAQ:THAR

THAR Rankings

#6175 Ranked by Market Cap
N/A Ranked by Dividends

THAR Latest News

Aug 13, 2025
Tharimmune Secures Key Global Patents for TH-104, Laying Foundation for Broader Indications Following Initial Development as a National Security Medical Countermeasure Against Weaponized Fentanyl
Aug 5, 2025
Nancy Davis, Visionary Philanthropist and Founder of Race to Erase MS and Cure Addiction Now Appointed to the Tharimmune Board of Directors
Aug 4, 2025
Tharimmune Issues Comprehensive Corporate Update including Lead TH104 as Critical National Security Solution Against Weaponized Fentanyl and TH023 Poised to Revolutionize Oral Antibody Delivery
Jul 23, 2025
Tharimmune Announces Pricing of $1.74 Million Registered Direct Public Offering of Common Stock and Warrants
Jun 17, 2025
Tharimmune Announces Key Leadership Appointments Including James Gordon Liddy Joining Board of Directors

THAR Latest SEC Filings

Aug 14, 2025
[10-Q] Tharimmune, Inc. Quarterly Earnings Report
Aug 7, 2025
[8-K] Tharimmune, Inc. Reports Material Event
Aug 6, 2025
[Form 4] Tharimmune, Inc. Insider Trading Activity
Aug 6, 2025
[Form 4] Tharimmune, Inc. Insider Trading Activity
Jul 31, 2025
[8-K] Tharimmune, Inc. Reports Material Event

THAR Stock Data

6.96M
3.57M
22.98%
1.47%
0.28%
Biotechnology
Pharmaceutical Preparations
United States
BRIDGEWATER